Skip to content

Drug and Alcohol Dependence

ISSN 0376-8716, 1879-0046

155 papers in the library · 2,092 citations · publishing 1978-2026

Papers

Sort Most recent Most cited

Individuals with cannabis use are associated with widespread morphological alterations in the subregions of the amygdala, hippocampus, and pallidum.

Drug and Alcohol Dependence October 1, 2022 Zhaoyang Cong, Yu Fu, Nan Chen et al.

Cannabis is the most frequently used illicit drug worldwide. Although multiple structural MRI studies of individuals with cannabis use (CB) have been undertaken, the reports of the volume alterations in the amygdala, hippocampus, and pallidum are not consistent. This study aims to detect subregion-level morphological alterations, analyze the correlation areas with cannabis usage...

Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions.

Drug and Alcohol Dependence August 19, 2022 Nicolas Garel, Christina Mcanulty, Kyle T. Greenway et al. 33 citations

BACKGROUND: Alcohol use disorder is highly prevalent and has important economical, societal, psychiatric, and medical consequences. All currently approved therapeutic approaches targeting alcohol dependence have relatively modest effects and high relapse rates. Recent evidence suggests that ketamine may be an effective intervention to treat alcohol use disorder and alcoholic withdrawal. This...

Examination of gamma-aminobutyric acid and glutamate-glutamine levels in association with impulsive behavior in adolescent marijuana users.

Drug and Alcohol Dependence April 1, 2022 Punitha Subramaniam, Andrew P Prescot, Erin McGlade et al.

Adolescent marijuana (MJ) use has been associated with alterations in brain structure and function as well as behavior. Examination of neurochemical correlates such as GABA (gamma-aminobutyric acid) and Glx (glutamate + glutamine) in MJ users remains limited. Impulsivity, identified as a risk factor and consequence of MJ use, has been associated with GABA and Glx levels in healthy and clinical...

THE EFFECTS OF MDMA-ASSISTED THERAPY ON ALCOHOL AND SUBSTANCE USE IN A PHASE 3 TRIAL FOR TREATMENT OF SEVERE PTSD

Drug and Alcohol Dependence February 1, 2022 Christopher R. Nicholas, Julie B. Wang, Allison R. Coker et al. 67 citations

Background Post-traumatic stress disorder (PTSD) is commonly associated with alcohol and substance use disorders (ASUD). A randomized, placebo-controlled, phase 3 trial demonstrated the safety and efficacy of MDMA-assisted therapy (MDMA-AT) for the treatment of severe PTSD. This analysis explores patterns of alcohol and substance use in patients receiving MDMA-AT compared to placebo plus...

Toward a typology of hallucinogen users in the United States.

Drug and Alcohol Dependence October 28, 2021 Christopher P Salas-Wright, James C Hodges, Audrey Hang Hai et al.

Background: Roughly one in ten American adults have used hallucinogens, and emerging evidence suggests that the prevalence of use is increasing. However, our understanding of the degree to which individuals "specialize" in the use of a particular hallucinogen or are poly-hallucinogen users remains incomplete. Methods: This study examined data from 6381 individuals reporting past-year...

DOI: 10.1016/j.drugalcdep.2021.109139 (opens in new tab) Full text (opens in new tab) Humans Substance-related disorders N-methyl-3,4-methylenedioxyamphetamine Hallucinogens +9

Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study.

Drug and Alcohol Dependence October 1, 2021 Valerio Ricci, Franca Ceci, Francesco di Carlo et al.

BACKGROUND Cannabis is the most used recreational drug worldwide. Its use can increase the risk of developing psychotic disorders and exacerbate their course. However, the relationship between cannabis use and dissociative symptoms has been scarcely investigated. AIMS To examine differences in psychotic and dissociative symptoms, and in functioning in first-episode psychotic patients (FEPp)...

Effect of Δ9-Tetrahydrocannabinol on Frontostriatal Resting State Functional Connectivity and Subjective Euphoric Response in Healthy Young Adults

Drug and Alcohol Dependence February 3, 2021 Natania A. Crane, K. Phan

Background: Few studies have examined how Δ9-Tetrahydrocannabinol (THC), the main psychoactive component of cannabis, impacts brain reward circuitry in humans. In this study, we examined if an acute dose of THC altered resting state functional connectivity between the striatum and prefrontal cortex among healthy young adults with limited cannabis use. Methods: Participants received THC (n=24)...

A within-person comparison of the subjective effects of higher vs. lower-potency cannabis.

Drug and Alcohol Dependence November 1, 2020 Sarah A. Okey, Madeline H. Meier

Cannabis concentrates have much higher concentrations of THC than marijuana (flower) and are quickly gaining popularity in the United States. One hypothesis is that use of higher-THC cannabis (concentrates) might result in greater intoxication and more severe acute negative effects than lower-THC cannabis (marijuana), but few studies have compared the subjective effects of concentrates and...

Drinking to death: Hyponatraemia induced by synthetic phenethylamines.

Drug and Alcohol Dependence July 1, 2020 Ana Carolina Faria, Helena Carmo, Félix Carvalho et al.

Synthetic phenethylamines are widely abused drugs, comprising new psychoactive substances such as synthetic cathinones, but also well-known amphetamines such as methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Cathinones and amphetamines share many toxicodynamic mechanisms. One of their potentially life-threatening consequences, particularly of MDMA, is serotonin-mediated...

DOI: 10.1016/j.drugalcdep.2020.108045 (opens in new tab) Full text (opens in new tab) 3,4-Methylenedioxymethamphetamine MDMA, Ecstasy Serotonin syndrome Synthetic cathinone

Trends in LSD use among US adults: 2015-2018.

Drug and Alcohol Dependence May 15, 2020 R. Yockey, Rebecca A. Vidourek, Keith A. King 111 citations

BACKGROUND The recent use of LSD to treat severe psychological disorders in several clinical applications has proven effective in reducing symptoms and distressing events. Trend analyses are warranted to provide the most current data for clinical and health interventions. The purpose of this study was to examine trends in LSD use among adults in the United States. METHODS A secondary analysis...

In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation.

Drug and Alcohol Dependence January 13, 2020 Michael D. Berquist, Sebastian Leth-Petersen, Jesper L. Kristensen et al.

BACKGROUND Recent clinical studies support the use of 3,4-methylenedioxymethamphetamine (MDMA) as an adjunct treatment for posttraumatic stress disorder (PTSD). Despite these promising findings, MDMA administration in controlled settings can increase blood pressure, heart rate, and body temperature. Previous studies indicate thatO-demethylated metabolites of MDMA contribute to its adverse...

Emergency department presentations related to acute toxicity following recreational use of cannabis products in Switzerland.

Drug and Alcohol Dependence 2020 Yasmin Schmid, Irene Scholz, Laura Mueller et al.

Concomitant use of cannabis and other psychoactive substances is common and it is often difficult to differentiate its acute effects from those of other substances. This study aimed to characterize the acute toxicity of cannabis with and without co-use of other substances. Retrospective analysis of cases presenting at the emergency departments of three large hospitals in Switzerland due to...

Drug checking services at music festivals and events in a Canadian setting.

Drug and Alcohol Dependence December 1, 2019 Karen McCrae, Samuel Tobias, Kenneth W. Tupper et al.

OBJECTIVES Drug checking is a harm reduction intervention that allows for identification of drug composition. The objective of the study was to assess drug market components and concordance between expected substance reported by clients and results from point-of-care drug checking at music festivals and events in British Columbia. METHODS From July to September 2018, we provided drug checking...

Mindfulness-oriented recovery enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial

Drug and Alcohol Dependence August 5, 2019 E. Garland, Adam W. Hanley, Anna Kline et al.

Background Methadone maintenance therapy (MMT) is an efficacious form of medication assisted treatment for opioid use disorder (OUD), yet many individuals on MMT relapse. Chronic pain and deficits in positive affective response to natural rewards may result in dysphoria that fuels opioid craving and promotes relapse. As such, behavioral therapies that ameliorate chronic pain and enhance...

Sex, THC, and hormones: Effects on density and sensitivity of CB1 cannabinoid receptors in rats.

Drug and Alcohol Dependence January 1, 2019 Charlotte E Farquhar, Christopher S Breivogel, Thomas F Gamage et al.

The recent NIH mandate to consider sex as a biological variable in preclinical research has focused attention on delineation of sex differences in behavior. To investigate mechanisms underlying sex differences in Δ9-tetrahydrocannabinol (THC) effects, we examined the effects of sex and gonadal hormones on CB1 receptors in cerebellum, hippocampus, prefrontal cortex, and striatum. Adult...

Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice.

Drug and Alcohol Dependence October 1, 2018 Kristen R Trexler, Sara R Nass, Molly S Crowe et al.

A subset of cannabis users develop some degree of Cannabis Use Disorder (CUD). Although behavioral therapy has some success in treating CUD, many users relapse, often citing altered sleep, mood, and irritability. Preclinical animal tests of cannabinoid withdrawal focus primarily on somatic-related behaviors precipitated by a cannabinoid receptor antagonist. The goal of the present study was to...

DOI: 10.1016/j.drugalcdep.2018.05.029 (opens in new tab) Full text (opens in new tab) Marijuana Cannabinoid withdrawal Cannabis use disorder Drug dependence +1

Made from concentrate? A national web survey assessing dab use in the United States.

Drug and Alcohol Dependence September 1, 2018 Kelly A. Sagar, Ashley M. Lambros, Mary Kathryn Dahlgren et al.

Cannabis concentrates, including dabs, contain extremely high levels of Δ9-tetrahydrocannabinol (THC). Although these products appear to be gaining popularity among recreational cannabis consumers, little data exists regarding concentrate use in the US. We conducted a national web-based survey to examine patterns of concentrate use, specifically dabbing. 4077 respondents completed a survey...

Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms.

Drug and Alcohol Dependence July 1, 2018 Sarah E. Priddy, Adam W. Hanley, Michael R. Riquino et al.

Opioid-treated chronic pain patients may be at risk for prescription opioid misuse due to heightened opioid craving coupled with deficits in attention to naturally rewarding, positive stimuli. Conversely, dispositional mindfulness, which is associated with reduced craving and increased responsiveness to natural rewards, may serve as a protective factor and buffer opioid misuse risk. The current...

The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.

Drug and Alcohol Dependence June 1, 2018 Nicolas J. Schlienz, Dustin C Lee, Maxine L Stitzer et al.

There is a clear need for advancing the treatment of cannabis use disorders. Prior research has demonstrated that dronabinol (oral THC) can dose-dependently suppress cannabis withdrawal and reduce the acute effects of smoked cannabis. The present study was conducted to evaluate whether high-dose dronabinol could reduce cannabis self-administration among daily users. Non-treatment seeking daily...

Altered attentional control strategies but spared executive functioning in chronic cannabis users.

Drug and Alcohol Dependence December 1, 2017 Amy T Nusbaum, Paul Whitney, Carrie Cuttler et al.

Cannabis use has increased rapidly in recent decades. The increase in cannabis use makes it important to understand the potential influence of chronic use on attentional control and other executive functions (EFs). Because cannabis is often used to reduce stress, and because stress can constrain attentional control and EFs, the primary goal of this study was to determine the joint effect of...

DOI: 10.1016/j.drugalcdep.2017.09.019 (opens in new tab) Full text (opens in new tab) Attentional control Cannabis use Cognitive flexibility Executive functions +1

Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.

Drug and Alcohol Dependence November 1, 2017 Sean B. Dolan, Michael J Forster, Michael B. Gatch

Novel psychoactive substances have maintained a prominent role in the global drug culture, despite increased regulation by governing bodies. Novel compounds continue to become available on the market, often in "Ecstasy" or "Molly" formulations in lieu of MDMA, at a much faster rate than they can be properly characterized. The current study aimed to investigate the discriminative stimulus and...

Synthetic cannabinoids found in "spice" products alter body temperature and cardiovascular parameters in conscious male rats.

Drug and Alcohol Dependence October 1, 2017 Charles W. Schindler, Benjamin R Gramling, Zuzana Justinova et al.

The misuse of synthetic cannabinoids is a persistent public health concern. Because these drugs target the same cannabinoid receptors as the active ingredient of marijuana, Δ9-tetrahydrocannabinol (THC), we compared the effects of synthetic cannabinoids and THC on body temperature and cardiovascular parameters. Biotelemetry transmitters for the measurement of body temperature or blood pressure...

Smoked marijuana attenuates performance and mood disruptions during simulated night shift work.

Drug and Alcohol Dependence September 1, 2017 Diana R Keith, Erik W. Gunderson, Margaret Haney et al.

Individuals who work nonstandard schedules, such as rotating or night shifts, are more susceptible to workplace injuries, performance decrements, and reduced productivity. This population is also almost twice as likely to use illicit drugs as individuals working a standard day shift. The purpose of this study was to examine the effects of smoked marijuana on performance, mood, and sleep during...

Heritability of lifetime ecstasy use.

Drug and Alcohol Dependence September 1, 2017 Karin J H Verweij, Jorien L Treur, Annabel Vreeker et al.

Ecstasy is a widely used psychoactive drug that users often take because they experience positive effects such as increased euphoria, sociability, elevated mood, and heightened sensations. Ecstasy use is not harmless and several immediate and long term side effects have been identified. Lifetime ecstasy use is likely to be partly influenced by genetic factors, but no twin study has determined...

Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress.

Drug and Alcohol Dependence August 1, 2017 Emma Childs, Joseph A Lutz, Harriet de Wit

Cannabis smokers often report that they use the drug to relax or to relieve emotional stress. However, few clinical studies have shown evidence of the stress-relieving effects of cannabis or cannabinoid agonists. In this study, we sought to assess the influence of delta-9-tetrahydrocannabinol (THC), a main active ingredient of cannabis, upon emotional responses to an acute psychosocial stressor...